Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 130

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 130
---
 comprehensive income (loss), before income taxes(141,672)68,501 (102,806)Less: Income tax (benefit) expense related to items of other comprehensive income (loss) (Note 12)(17,903)4,071 (1,905)Comprehensive income (loss), net of income taxes(98,478)544,800 391,707 Less: Comprehensive income related to noncontrolling interests, net of income taxes237 4,546 2,798 Comprehensive income (loss) attributable to common shareholders, net of income taxes$(98,715)$540,254 $388,909 See Notes to Consolidated Financial Statements.

60

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CONSOLIDATED BALANCE SHEETS(in thousands, except per share amounts)

December 28, 2024December 30, 2023Assets  Current assets:  Cash and cash equivalents$194,606 $276,771 Trade receivables and contract assets, net of allowances for credit losses of $18,301 and $25,722, respectively720,915 780,375 Inventories278,544 380,259 Prepaid assets103,210 87,879 Other current assets105,796 83,378 Total current assets1,403,071 1,608,662 Property, plant and equipment, net1,604,014 1,639,741 Venture capital and strategic equity investments218,350 243,811 Operating lease right-of-use assets, net412,490 394,029 Goodwill2,846,608 3,095,045 Intangible assets, net723,400 864,051 Deferred tax assets42,179 40,279 Other assets278,233 309,383 Total assets$7,528,345 $8,195,001 Liabilities, Redeemable Noncontrolling Interests and Equity  Current liabilities:  Accounts payable$140,337 $168,937 Accrued compensation179,418 213,290 Deferred revenue248,322 241,820 Accrued liabilities232,010 227,825 Other current liabilities194,014 203,210 Total current liabilities994,101 1,055,082 Long-term debt, net and finance leases2,240,205 2,647